Espinoza Andres F, Shetty Priya B, Jacobson Jillian C, Todd Hannah, Harrell Kelley, Trappey Alfred F, Doski John, Castro Eumenia C, Montgomery Nicole I, Okcu M Fatih, Venkatramani Rajkumar, Chung Dai H, Vasudevan Sanjeev A
Texas Children's Surgical Oncology Program and Liver Tumor Program, Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Department of Pediatric Hematology and Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Cancer Med. 2024 Sep;13(17):e70207. doi: 10.1002/cam4.70207.
Synovial sarcoma is one of the most common soft tissue sarcomas in children. Guidelines regarding the adequate extent of resection margins and the role of re-resection are lacking. We sought to evaluate the adequate resection margin and the role of re-resection in predicting outcomes in children with synovial sarcomas.
A cohort of 36 patients less than 18 years of age at diagnosis who were treated for localized synovial sarcoma at three tertiary pediatric hospitals between January 2004 and December 2020 were included in this study. Patient and tumor demographics, treatment information, and margin status after surgical resection were collected from the medical record. Clinical, treatment, and surgical characteristics, as well as outcomes including hazard ratios (HRs), event-free survival (EFS), and overall survival (OS) were compared by resection margins group and re-resection status.
Patients in the R1 resection group were significantly more likely to relapse or die compared to patients in the R0 resection group. However, there was no significant difference in EFS (HR 0.52, p = 0.54) or OS (HR 1.56, p = 0.719) in R0 patients with less than 5 mm margins compared to R0 patients with more than 5 mm margins. Patients with R1 on initial or re-resection had significantly worse OS than patients who had R0 resection on initial or re-resection (HR = 10.12, p = 0.005).
This study re-affirms that R0 resection is an independent prognostic predictor of better OS/EFS in pediatric synovial sarcoma. Second, our study extends this finding to report negative margins on initial resection or re-resection is associated with better OS/EFS than positive margins on initial resection or re-resection. Lastly, we found that there is no difference in outcomes associated with re-resection or <5 mm margins for R0 patients, indicating that re-resection and <5 mm margins are acceptable if microscopic disease is removed.
滑膜肉瘤是儿童最常见的软组织肉瘤之一。目前缺乏关于切除边缘足够范围以及再次切除作用的指南。我们旨在评估足够的切除边缘以及再次切除在预测滑膜肉瘤患儿预后中的作用。
本研究纳入了2004年1月至2020年12月期间在三家三级儿科医院接受局限性滑膜肉瘤治疗、诊断时年龄小于18岁的36例患者。从病历中收集患者和肿瘤的人口统计学信息、治疗信息以及手术切除后的边缘状态。通过切除边缘组和再次切除状态比较临床、治疗和手术特征以及包括风险比(HRs)、无事件生存期(EFS)和总生存期(OS)在内的预后。
与R0切除组患者相比,R1切除组患者复发或死亡的可能性显著更高。然而,与边缘大于5mm的R0患者相比,边缘小于5mm的R0患者在EFS(HR 0.52,p = 0.54)或OS(HR 1.56,p = 0.719)方面没有显著差异。初次或再次切除为R1的患者的OS明显比初次或再次切除为R0的患者差(HR = 10.12,p = 0.005)。
本研究再次证实,R0切除是小儿滑膜肉瘤中OS/EFS更好的独立预后预测因素。其次,我们的研究扩展了这一发现,报告初次切除或再次切除时切缘阴性与初次切除或再次切除时切缘阳性相比,OS/EFS更好。最后,我们发现R0患者再次切除或边缘<5mm的预后没有差异,这表明如果切除了微小病灶,再次切除和<5mm的边缘是可以接受的。